Results 81 to 90 of about 3,616 (129)

Mapping Evidence on the Regulations Affecting the Accessibility, Availability, and Management of Snake Antivenom Globally: A Scoping Review. [PDF]

Trop Med Infect Dis
Majeed R, Bester J, Kgarosi K, Strydom M.   +3 more
europepmc   +1 more source

Pharmacokinetics of Snake Antivenom Following Intravenous and Intramuscular Administration in Envenomed Large Animal Model. [PDF]

Pharmaceutics
Gamulin E, Mateljak Lukačević S, Lang Balija M, Smajlović A, Vnuk D, Gulan Harcet J, Tomičić M, Hećimović A, Halassy B, Kurtović T.   +9 more
europepmc   +1 more source

Correction: Majeed et al. Mapping Evidence on the Regulations Affecting the Accessibility, Availability, and Management of Snake Antivenom Globally: A Scoping Review. <i>Trop. Med. Infect. Dis.</i> 2025, <i>10</i>, 228. [PDF]

Trop Med Infect Dis
Majeed R, Bester J, Kgarosi K, Strydom M.   +3 more
europepmc   +1 more source

Spatial Accessibility Analysis of Snake Antivenom. [PDF]

Int J Public Health
Hao W, He L, Song X, Wang J, Hu Y, Chen Y, Lv C, Yan S.   +7 more
europepmc   +1 more source

Mapping evidence on the regulations affecting accessibility, availability and management of snake antivenom globally: a scoping review protocol. [PDF]

BMJ Open
Majeed R, Bester J, Kgarosi K, Strydom M.   +3 more
europepmc   +1 more source

Snakebites in Cameroon: Tolerance of a Snake Antivenom (Inoserp™ PAN-AFRICA) in Africa in Real-Life Conditions. [PDF]

Toxins (Basel)
Benhammou D, Chippaux JP, Ntone R, Madec Y, Amta P, Noel G, Karl FN, Perilhou A, Matchim L, Sanchez M, Ndifon M, Clauteaux P, Eteki L, Boum Y, Nkwescheu AS, Taieb F.   +15 more
europepmc   +1 more source

Stress levels, hematological condition, and productivity of plasma-producing horses used for snake antivenom manufacture: A comparison of two industrial bleeding methods. [PDF]

Toxicon X
Arias-Esquivel AM, Moscoso E, Umaña D, Arguedas M, Solano D, Durán G, Gómez A, Gutiérrez JM, León G.   +8 more
europepmc   +1 more source

Design, development and preclinical assessment of MENAVip-ICP, a new snake antivenom with potential coverage of species in the Middle East and North Africa regions. [PDF]

Toxicon X
Segura Á, Moscoso E, Umaña D, Vargas M, Sánchez A, Hernández A, Durán G, Villalta M, Gómez A, Herrera M, Arguedas M, Gutiérrez JM, León G.   +12 more
europepmc   +1 more source

Use of snake antivenom in the Region of the Americas: a systematic review. [PDF]

Bull World Health Organ
Guerra-Duarte C, de Sousa VP, de Oliveira-Sousa G, Gomes Mol MP.   +3 more
europepmc   +1 more source

The Papua New Guinea snakebite partnership: a retrospective study of snakebite epidemiology and management, 2018-2023. [PDF]

Front Toxicol
Roalakona G, Maru A, Jackson TNW, Matainaho T, Nou G, Tefuarani N, Watt AD.   +6 more
europepmc   +1 more source